Related Experiment Video

Updated: Aug 23, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Donor lymphocyte infusions after reduced intensity conditioning allogeneic transplantation: what we need to know

David I Marks, Anne Parker, Stephen P Robinson

    Blood
    |June 23, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
    09:48

    Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

    Published on: September 26, 2019

    In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
    18:48

    In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

    Published on: August 12, 2017

    Related Experiment Videos

    Last Updated: Aug 23, 2026

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
    11:55

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

    Published on: March 14, 2011

    Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
    09:48

    Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

    Published on: September 26, 2019

    In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
    18:48

    In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

    Published on: August 12, 2017

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Tissue Transplantation01:24

    Tissue Transplantation

    Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
    The Biology of Tissue Transplantation
    The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

    Articles linked to this work by shared authors, journal, and citation graph.

    Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

    Blood advances·2025

    Ocean soundscapes and trends from 2003 to 2021: 10-100 Hz.

    The Journal of the Acoustical Society of America·2025

    Writing a Medical Memoir: Lessons From a Long, Steep Road.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

    CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A Podcast.

    Targeted oncology·2025

    Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review.

    Expert review of hematology·2025

    Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.

    Cancer·2024

    The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

    Blood·2026

    Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

    Blood·2026

    How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

    Blood·2026

    Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

    Blood·2026

    Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

    Blood·2026

    CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

    Blood·2026

    Predictive Value of HLA-Derived T-Cell Epitope and B-Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes.

    Clinical transplantation·2026

    Donor lymphocyte infusion as immune modulation after pediatric allogeneic transplantation.

    Blood immunology & cellular therapy·2026

    Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.

    Frontiers in immunology·2026

    Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?

    Journal of cardiac failure·2026

    Early Results of Beating-Heart Transplantation After Thoraco-Abdominal Normothermic Regional Perfusion in Controlled Donation After Circulatory Death Donors.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

    Persistent expression of recipient-type ABH antigen following ABO-incompatible stem cell transplantation despite complete donor-type chimerism.

    Blood cell therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us